Skip to content

Use of Virtual Reality Mask During Blood and Skin Allergic Tests in 7 to 13 Children

Evaluation of the Use of a Virtual Reality Mask During Blood Tests and Prick Tests Performed in Allergic Children Aged 7 to 13 Years: a Multicenter, Randomized Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05378581
Acronym
REVAPRICK
Enrollment
300
Registered
2022-05-18
Start date
2022-09-23
Completion date
2026-04-30
Last updated
2026-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety and Fear, Children, Only, Pain, Procedural, Virtual Reality

Keywords

virtual reality mask, children from 7 to 13, allergic pricks tests, consultation and pediatric's day hospital

Brief summary

Main objective : Evaluate the effect of using a virtual reality mask during the blood test and pricks tests in allergic children aged from 7 to 13 years. Hypothesis : Using virtual reality mask during blood test and pricks tests for allergic kids from 7 to 13 would reduce anxiety and pain

Detailed description

Investigation of food or respiratory allergy is based on prick tests and serum specific immunoglobulin E assays. The nurse often controls the blood test pain but during the skin tests, many children cry, feeling both fear and pain. This traumatic experience will in most cases be repeated during the child's allergic follow-up. To date, there are few effective means of limiting anxiety and pain associated with prick tests and therefore little research work on this subject. Immersion in virtual reality (VR) seems to be an interesting way of distraction for children from 7 to 13 years needing this treatment. Indeed, it makes it possible to saturate the sensorially of the child thus reducing the nociceptive perceptions and the anxiety. The choice of VR mask with pediatric program specific seems interesting for this children This is a randomized, open-label, two-armed parallel, multicenter therapeutic trial comparing an analgesic strategy using authorized medical devices (conventional strategy) with a virtual reality mask distraction technique for allergics tests in children from 7 to 13 years old hospitalized in the pediatric consultation of Clermont Ferrand University Hospital and in the day hospital of Saint-Etienne University Hospital The control arm is the local anesthetic cream (for the blood test) arm with distraction from nurse/parents +/-anesthesic and anxiolytic gas and the experimental arm is the local anesthetic cream + virtual reality mask distraction The nurse informs and obtains the consent of the child and his parents. Then she measures child's pain and anxiety before the care, during the blood test, at the third prick test and immediately after the care. She also notes the anxiety of the parents before and after the care. Finally, the satisfaction of the child, parents, nurses will be collected at the end of the care. After statistical analysis of these two arms, it will be possible to determine the value of the virtual reality mask to reduce the child's pain and anxiety during the pricks tests.

Interventions

virtual reality mask Deepsen® with age-appropriate software Birdy®

OTHERcontrol arm

usual process

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Randomized, controlled, open-label, two arms parallel, multicenter therapeutic trial

Eligibility

Sex/Gender
ALL
Age
7 Years to 13 Years
Healthy volunteers
No

Inclusion criteria

* Children from 7 to 13 years old requiring blood test and prick tests in pediatric consultation at the Clermont-Ferrand University Hospital and in the pediatric's day hospital at the Saint-Etienne University Hospital * Subjects and their parents who were informed about the study and gave informed consent * Enrollment in the Social Security system * Children and parents able to use the self-report scales proposed in the study

Exclusion criteria

Children from 7 to 13 : * presenting a contraindication to the use of the virtual reality mask: heart disease, epilepsy, psychiatric illness (major anxiety, post-traumatic stress disorder) * Having a modification of pain's integration (spina bifida for example) * Having received an analgesic before the care * Requiring contact isolation * With a history of seizures or motion sickness * Refusal of the parents and/or the child

Design outcomes

Primary

MeasureTime frameDescription
children's pain hetero-evaluationduring blood testchildren's pain evaluation by the nurse with the visual analog scale quote from 0 to 10, 10=worst score
children's pain self-evaluation5 min after the careself evaluation of children's pain with the visual analog scale in vertical position quote from 0 to 10, 10=worst score

Secondary

MeasureTime frameDescription
change from baseline children's anxiety at just after the carebefore the care and 5 min after the careself-evaluation of children's anxiety with the scale "child fear scale" quote from 0 to 4, 4= worst score
children's anxiety hetero evaluationduring blood testchildren's anxiety evaluation by the nurse with the scale "child fear scale" quote from 0 to 4, 4= worst score
change from baseline parents' anxiety at just after the carebefore the care and 5 min after the careself-evaluation of parents' anxiety with the numerical scale quote from 1 to 10, 10= worst score
evaluation of the care5 min after the caresatisfaction of the care for children, parents and nurses with satisfaction questionnaire for children : a score from 1 to 3 (3=best score, very satisfied) for parents with a score from 1 to 5 (5= best score, very satisfied) and for nurse with a score from 1 to 5 (5= best score, very satisfied)

Countries

France

Contacts

PRINCIPAL_INVESTIGATORAlexandra USCLADE

University Hospital, Clermont-Ferrand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 9, 2026